Cargando…
Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy
OBJECTIVE: To analyze the therapeutic effect of uterine artery embolisation (UAE) in patients with cesarean section pregnancy (CSP) delivered by cesarean section and the effect on serum human chorionic gonadotrophin (β-HCG) levels and reproductive function. METHODS: In total 142 patients with CSP, T...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847222/ https://www.ncbi.nlm.nih.gov/pubmed/35187063 http://dx.doi.org/10.3389/fsurg.2022.838879 |
_version_ | 1784652007158579200 |
---|---|
author | Zhu, Wenyang Zhang, Xiaofang Liu, Chang Liu, Yang Xu, Wei |
author_facet | Zhu, Wenyang Zhang, Xiaofang Liu, Chang Liu, Yang Xu, Wei |
author_sort | Zhu, Wenyang |
collection | PubMed |
description | OBJECTIVE: To analyze the therapeutic effect of uterine artery embolisation (UAE) in patients with cesarean section pregnancy (CSP) delivered by cesarean section and the effect on serum human chorionic gonadotrophin (β-HCG) levels and reproductive function. METHODS: In total 142 patients with CSP, The control group (n = 71) received Methotrexate (MTX) with ultrasound monitoring after admission and the research group (n = 71) was treated with UAE on basic of the control group. The two groups were compared in terms of treatment outcome, intraoperative bleeding, bed activity, vaginal bleeding and length of hospital stay, and serum follicle stimulating hormone (FSH), oestradiol (E2), luteinising hormone (LH) and β-HCG levels at 1 month postoperatively. The clinical symptoms (normalization of β-HCG and return of menstruation) and clinical outcomes (normal pregnancy, recurrent scar pregnancy) were compared between the two groups, as well as the occurrence of post-operative complications in both groups. RESULTS: Compared with the control group, the research group had a higher overall near-term effective rate, a lower recurrence rate of CSP in pregnancy, and a lower complication rate (P < 0.05); meanwhile, the time to get out of bed, postoperative vaginal bleeding, length of hospital stay, normalization of serum β-HCG, and return to menstruation were shorter in the research group than in the control group (P < 0.05); In addition, serum FSH, E2, LH and β-HCG levels improved better in the research group compared with the control group 1 month after surgery (P < 0.05). CONCLUSION: The treatment of CSP patients with UAE can reduce the amount of intraoperative bleeding and the duration of vaginal bleeding, promote the improvement of patients' clinical symptoms, have less impact on the disruption of patients' sex hormone balance, reduce patients' surgical risks to a greater extent, preserve patients' normal fertility, and have better application. |
format | Online Article Text |
id | pubmed-8847222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88472222022-02-17 Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy Zhu, Wenyang Zhang, Xiaofang Liu, Chang Liu, Yang Xu, Wei Front Surg Surgery OBJECTIVE: To analyze the therapeutic effect of uterine artery embolisation (UAE) in patients with cesarean section pregnancy (CSP) delivered by cesarean section and the effect on serum human chorionic gonadotrophin (β-HCG) levels and reproductive function. METHODS: In total 142 patients with CSP, The control group (n = 71) received Methotrexate (MTX) with ultrasound monitoring after admission and the research group (n = 71) was treated with UAE on basic of the control group. The two groups were compared in terms of treatment outcome, intraoperative bleeding, bed activity, vaginal bleeding and length of hospital stay, and serum follicle stimulating hormone (FSH), oestradiol (E2), luteinising hormone (LH) and β-HCG levels at 1 month postoperatively. The clinical symptoms (normalization of β-HCG and return of menstruation) and clinical outcomes (normal pregnancy, recurrent scar pregnancy) were compared between the two groups, as well as the occurrence of post-operative complications in both groups. RESULTS: Compared with the control group, the research group had a higher overall near-term effective rate, a lower recurrence rate of CSP in pregnancy, and a lower complication rate (P < 0.05); meanwhile, the time to get out of bed, postoperative vaginal bleeding, length of hospital stay, normalization of serum β-HCG, and return to menstruation were shorter in the research group than in the control group (P < 0.05); In addition, serum FSH, E2, LH and β-HCG levels improved better in the research group compared with the control group 1 month after surgery (P < 0.05). CONCLUSION: The treatment of CSP patients with UAE can reduce the amount of intraoperative bleeding and the duration of vaginal bleeding, promote the improvement of patients' clinical symptoms, have less impact on the disruption of patients' sex hormone balance, reduce patients' surgical risks to a greater extent, preserve patients' normal fertility, and have better application. Frontiers Media S.A. 2022-02-02 /pmc/articles/PMC8847222/ /pubmed/35187063 http://dx.doi.org/10.3389/fsurg.2022.838879 Text en Copyright © 2022 Zhu, Zhang, Liu, Liu and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Surgery Zhu, Wenyang Zhang, Xiaofang Liu, Chang Liu, Yang Xu, Wei Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy |
title | Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy |
title_full | Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy |
title_fullStr | Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy |
title_full_unstemmed | Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy |
title_short | Uterine Artery Embolization on Serum β-HCG Levels, Fertility Function and Clinical Efficacy in Patients With Cesarean Uterine Scar Pregnancy |
title_sort | uterine artery embolization on serum β-hcg levels, fertility function and clinical efficacy in patients with cesarean uterine scar pregnancy |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847222/ https://www.ncbi.nlm.nih.gov/pubmed/35187063 http://dx.doi.org/10.3389/fsurg.2022.838879 |
work_keys_str_mv | AT zhuwenyang uterinearteryembolizationonserumbhcglevelsfertilityfunctionandclinicalefficacyinpatientswithcesareanuterinescarpregnancy AT zhangxiaofang uterinearteryembolizationonserumbhcglevelsfertilityfunctionandclinicalefficacyinpatientswithcesareanuterinescarpregnancy AT liuchang uterinearteryembolizationonserumbhcglevelsfertilityfunctionandclinicalefficacyinpatientswithcesareanuterinescarpregnancy AT liuyang uterinearteryembolizationonserumbhcglevelsfertilityfunctionandclinicalefficacyinpatientswithcesareanuterinescarpregnancy AT xuwei uterinearteryembolizationonserumbhcglevelsfertilityfunctionandclinicalefficacyinpatientswithcesareanuterinescarpregnancy |